Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017 Lonza Group Announces The Successful Results Of The Rights Offering May 10, 2017 Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients January 9, 2018
Acelity Launches PREVENA DUO Incision Management System Platform —The First Single-Use Negative Pressure Wound Therapy (NPWT) System For The Simultaneous Management Of Two Incisions May 23, 2017
